Skip to content
bezafibrate
EntityQ577387· pop 18· linked from 145 articles

bezafibrate

Sign in to save

Also known as Bezalip®, Cedur, Befizal, Bezafibratum, Bezafibrato, Bezafibrat, 2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid, Bezalip

Bezafibrate (marketed as Bezalip and various other brand names) is a fibrate drug used as a lipid-lowering agent to treat hyperlipidaemia. It helps to lower LDL cholesterol and triglyceride in the blood, and increase HDL.

~4 min read

Encyclopedic overview

7 sections
Contents
  • Medical uses
  • Side effects
  • Other uses
  • Mode of action
  • Synthesis
  • History
  • References

{{Drugbox | verifiedrevid = 443667625 | IUPAC_name = 2-(4-{2-[(4-chlorobenzoyl)amino]ethyl}phenoxy)-2-methylpropanoic acid | image = Bezafibrate.svg | image_class = skin-invert-image

| tradename = | Drugs.com = | MedlinePlus = a682711 | pregnancy_category = | legal_UK = POM | legal_US = Rx-only | routes_of_administration = Oral

Excerpted from Wikipedia’s “bezafibrate” article, available under the CC BY-SA 4.0 licence.